Benzinga··Vandana SinghFDA Clears Oral Combination Therapy for Untreated Chronic Lymphocytic Leukemia
FDA approves first all-oral combination therapy for untreated chronic lymphocytic leukemia. The fixed-duration treatment showed 35% reduced progression risk versus chemotherapy.
ABBVRHHBYAZNFDA approvalPhase 3 trial